It can therefore be assumed that the IL-22/STAT3 pathway may influence the pathogenesis of RA, with particular emphasis on the impact on RA-FLS survival, which may be one of the RA therapeutic pathways. The gene discussed is STAT3; the disease is rheumatoid arthritis.